CONTINUOUS EVIDENCE ORCHESTRATION: A HUMAN-GOVERNED, MCP-CONNECTED MULTI-AGENT GENAI PIPELINE FOR HEOR AND HTA

Author(s)

Inderpreet S. Marwaha, MSc, RPh1, Ankita Sood, PharmD1, Rajdeep Kaur, PhD1, Shubhram Pandey, MSc2, Barinder Singh, RPh3, Sukriti Sharma, MSc1.
1Pharmacoevidence Pvt. Ltd., Mohali, India, 2Pharmacoevidence Pvt. Ltd., SAS Nagar, Mohali, India, 3Pharmacoevidence Pvt. Ltd., SAS Nagar Mohali, India.
OBJECTIVES: HEOR teams increasingly rely on separate GenAI-assisted modules for literature review, comparative analyses, economic modelling, and dossier compilation. Operating in isolation, however, they remain fragmented and fall out of sync, leaving dossiers built on outdated evidence. We aimed to connect them into one continuously updated, human-governed pipeline from research question to HTA readiness.
METHODS: We built a connecting layer using the Model Context Protocol (MCP), which lets HEOR modules automatically exchange structured evidence through a common data model. Each module runs reasoning loops to reach the task goal. Human governance is built in, with expert validation and auditable, rationale-backed decisions at each step, aligned with Cochrane RAISE guidance for responsible AI. The pipeline is designed to meet the evidence requirements of the EU HTA Regulation, JCA guidance, and national submission formats.
RESULTS: The framework links the modules as ordered, MCP-connected stages, each governed by an expert checkpoint: (i) landscape assessment frames the research question; (ii) a living SLR layer keeps evidence current via scheduled and event-based updates, with confidence-scored decisions; (iii) extracted evidence is consolidated into evidence tables, maps, the PICOS set, and generation plan driving downstream work; (iv) comparative analysis runs feasibility assessment, NMA, and ITC; (v) economic analyses are developed, then updated and adapted as evidence and country requirements change; and (vi) reports and dossiers generation yields HTA-ready outputs with automated QA, appraisal simulation, and translation. The pipeline thus maintains one evidence base that is current, portable, and reusable across deliverables.
CONCLUSIONS: Connecting standalone GenAI-assisted HEOR modules through MCP into one human-governed pipeline keeps evidence current, portable, and reusable, while preserving expert oversight and auditable, RAISE-aligned decisions across the evidence chain.

Conference/Value in Health Info

2026-11, ISPOR Europe 2026, Vienna, Austria

Value in Health, Volume 29, Issue 12S

Code

MSR49

Topic

Health Technology Assessment, Methodological & Statistical Research

Topic Subcategory

Artificial Intelligence, Machine Learning, Predictive Analytics

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×